Alternatives for microdosing GLP-1 medications include a slower titration phase, switching to a different medication, or managing the side effects with lifestyle modifications
And while theyre cheaper, they come with higher risk
Eating protein helps mitigate those effects
Complementing randomized trial evidence, extensive real-world observational data from large healthcare databases consistently demonstrate associations between GLP-1 receptor agonist utilization and decreased risks of MALOs involving cirrhosis, hepatic decompensation, HCC, and death from hepatic causes in patients with MASLD and type 2 diabetes
As Zielke articulates: If something is really of interest, then you are willing to invest the extra time and effort needed, she said
This dual mechanism, eating less while burning more, accounts for the superior weight loss outcomes observed in clinical trials